Deferred Tax Assets, Gross of 10x Genomics, Inc. from 31 Dec 2018 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
- Summary
-
10x Genomics, Inc. quarterly Deferred Tax Assets, Gross in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
- 10x Genomics, Inc. Deferred Tax Assets, Gross for the quarter ending 31 Dec 2025 was $505,840,000, a 1.9% increase year-over-year.
- Source SEC data
- View on sec.gov
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)
10x Genomics, Inc. Quarterly Deferred Tax Assets, Gross (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $505,840,000 | +$9,669,000 | +1.9% | 31 Dec 2025 | 10-K | 13 Feb 2026 | 2025 | FY |
| Q4 2024 | $496,171,000 | +$35,719,000 | +7.8% | 31 Dec 2024 | 10-K | 13 Feb 2026 | 2025 | FY |
| Q4 2023 | $460,452,000 | +$77,741,000 | +20% | 31 Dec 2023 | 10-K | 13 Feb 2025 | 2024 | FY |
| Q4 2022 | $382,711,000 | +$52,099,000 | +16% | 31 Dec 2022 | 10-K | 15 Feb 2024 | 2023 | FY |
| Q4 2021 | $330,612,000 | +$129,696,000 | +65% | 31 Dec 2021 | 10-K | 16 Feb 2023 | 2022 | FY |
| Q4 2020 | $200,916,000 | +$129,507,000 | +181% | 31 Dec 2020 | 10-K | 18 Feb 2022 | 2021 | FY |
| Q4 2019 | $71,409,000 | +$15,276,000 | +27% | 31 Dec 2019 | 10-K | 26 Feb 2021 | 2020 | FY |
| Q4 2018 | $56,133,000 | 31 Dec 2018 | 10-K | 27 Feb 2020 | 2019 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.